VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $76,000 | +181.5% | 10,000 | 0.0% | 0.01% | +200.0% |
Q4 2021 | $27,000 | -73.8% | 10,000 | -60.0% | 0.00% | -76.5% |
Q2 2021 | $103,000 | +505.9% | 25,000 | +2400.0% | 0.02% | +240.0% |
Q3 2019 | $17,000 | -37.0% | 1,000 | 0.0% | 0.01% | -28.6% |
Q2 2019 | $27,000 | +42.1% | 1,000 | 0.0% | 0.01% | +16.7% |
Q1 2019 | $19,000 | +111.1% | 1,000 | 0.0% | 0.01% | +100.0% |
Q4 2018 | $9,000 | -52.6% | 1,000 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $19,000 | -5.0% | 1,000 | 0.0% | 0.01% | -14.3% |
Q2 2018 | $20,000 | -47.4% | 1,000 | -50.0% | 0.01% | -41.7% |
Q1 2018 | $38,000 | -42.4% | 2,000 | -50.0% | 0.01% | -42.9% |
Q4 2017 | $66,000 | +61.0% | 4,000 | +100.0% | 0.02% | +50.0% |
Q3 2017 | $41,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |